Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
-13.04%
Price
06.02.26
€0.52
Summary
This prediction is currently active. The prediction for Immunic Inc. disappoints with a performance of -13.04%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | -0.574% | -0.574% |
| iShares Core DAX® | 1.085% | -0.846% |
| iShares Nasdaq 100 | -1.665% | -3.306% |
| iShares Nikkei 225® | 3.863% | 6.308% |
| iShares S&P 500 | 0.111% | -1.337% |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat